NCPA Media: NCPA in the News

  • Oct 01, 2015

    NCPA: Mergers, market manipulation fuel rise in generic-drug prices

    American Pharmacy News: “Wholesale generic drugs are facing less market competition, which is driving up their prices,” says NCPA Senior Fellow Devon Herrick in an American Pharmacy News story.

  • Sep 29, 2015

    Detroit's new cancer facility aims to spark economic growth

    Modern Healthcare: “States are increasingly approving multiple healthcare facilities in one vicinity to promote market competition,” says NCPA Senior Fellow Devon Herrick in a Modern Healthcare story.

  • Sep 25, 2015

    Flawed study urges government support for solar power industry

    Natural News: Natural News article cites NCPA research about the detrimental economic impacts of switching from natural gas to solar energy, pointing out the detrimental cost to tax payers and the lack of high paying jobs associated with solar power.

  • Sep 24, 2015

    Should Government Control The Price Of Prescription Drugs?

    International Business Times: “Shrinking the FDA to reduce the amount of money pharmaceutical companies must spend to create new medicines isthe smartest approach to lowering drug costs,” says NCPA Senior Fellow John R. Graham in an International Business Times story.

  • Sep 22, 2015

    Allen West and Brian Kilmeade on Current Events

    Kilmeade & Friends: Brian Kilmeade interviews NCPA President/CEO Allen West about his stance on the Iran Deal, Russian/Iranian relations, the Refugee Crisis, and West’s wish to see a Constitutional Conservative win the Presidential Race on Kilmeade & Friends.

  • Sep 22, 2015

    Refugee Crisis

    Fox & Friends: NCPA President/CEO Allen West discusses extensive military and veteran funding cuts, while pointing out numerous refugee resettlement grants and welfare benefits in an interview with Steve Doocy on Fox & Friends.

  • Sep 22, 2015

    Legal Drug Dealers Commit Highway Robbery

    Town Hall: “Manufacturers are raising prices on old remedies because there is little competition in treating rare diseases in the United States,” says NCPA Senior Fellow Devon Herrick in a Town Hall commentary.

  • Sep 21, 2015

    Could Supply Issues Price Consumers Out of Generic Drugs? NCPA Senior Fellow Devon Herrick cites market consolidation, product dumping, and raw material shortages as reasons for growing generic drug costs, according to a article.

porno izle